145 related articles for article (PubMed ID: 16801915)
1. Fractalkine: moving from chemotaxis to neuroprotection.
Ré DB; Przedborski S
Nat Neurosci; 2006 Jul; 9(7):859-61. PubMed ID: 16801915
[No Abstract] [Full Text] [Related]
2. Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity.
Limatola C; Lauro C; Catalano M; Ciotti MT; Bertollini C; Di Angelantonio S; Ragozzino D; Eusebi F
J Neuroimmunol; 2005 Sep; 166(1-2):19-28. PubMed ID: 16019082
[TBL] [Abstract][Full Text] [Related]
3. Role of fractalkine (CX3CL1) in regulating neuron-microglia interactions: development of viral-based CX3CR1 antagonists.
Streit WJ; Davis CN; Harrison JK
Curr Alzheimer Res; 2005 Apr; 2(2):187-9. PubMed ID: 15974917
[TBL] [Abstract][Full Text] [Related]
4. Chemokines and chemokine receptors: multipurpose players in neuroinflammation.
Ransohoff RM; Liu L; Cardona AE
Int Rev Neurobiol; 2007; 82():187-204. PubMed ID: 17678962
[TBL] [Abstract][Full Text] [Related]
5. Fractalkine-upregulated milk-fat globule EGF factor-8 protein in cultured rat microglia.
Leonardi-Essmann F; Emig M; Kitamura Y; Spanagel R; Gebicke-Haerter PJ
J Neuroimmunol; 2005 Mar; 160(1-2):92-101. PubMed ID: 15710462
[TBL] [Abstract][Full Text] [Related]
6. Fractalkine expression in the rhesus monkey brain during lentivirus infection and its control by 6-chloro-2',3'-dideoxyguanosine.
Depboylu C; Eiden LE; Schäfer MK; Reinhart TA; Mitsuya H; Schall TJ; Weihe E
J Neuropathol Exp Neurol; 2006 Dec; 65(12):1170-80. PubMed ID: 17146291
[TBL] [Abstract][Full Text] [Related]
7. Modulation of atherogenesis by chemokines.
Boisvert WA
Trends Cardiovasc Med; 2004 May; 14(4):161-5. PubMed ID: 15177267
[TBL] [Abstract][Full Text] [Related]
8. The CX3C chemokine fractalkine induces vascular dysfunction by generation of superoxide anions.
Schäfer A; Schulz C; Fraccarollo D; Tas P; Leutke M; Eigenthaler M; Seidl S; Heider P; Ertl G; Massberg S; Bauersachs J
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):55-62. PubMed ID: 17082482
[TBL] [Abstract][Full Text] [Related]
9. [Adhesional chemokine, fractalkine].
Umehara H
Nihon Rinsho Meneki Gakkai Kaishi; 2000 Apr; 23(2):90-102. PubMed ID: 10863324
[No Abstract] [Full Text] [Related]
10. Hypoxia-induced astrocytes promote the migration of neural progenitor cells via vascular endothelial factor, stem cell factor, stromal-derived factor-1alpha and monocyte chemoattractant protein-1 upregulation in vitro.
Xu Q; Wang S; Jiang X; Zhao Y; Gao M; Zhang Y; Wang X; Tano K; Kanehara M; Zhang W; Ishida T
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):624-31. PubMed ID: 17581219
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of fractalkine: a novel approach to metastatic colon cancer.
Brueckmann M; Borggrefe M
Gut; 2007 Mar; 56(3):314-6. PubMed ID: 17339240
[TBL] [Abstract][Full Text] [Related]
12. Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system.
Tong N; Perry SW; Zhang Q; James HJ; Guo H; Brooks A; Bal H; Kinnear SA; Fine S; Epstein LG; Dairaghi D; Schall TJ; Gendelman HE; Dewhurst S; Sharer LR; Gelbard HA
J Immunol; 2000 Feb; 164(3):1333-9. PubMed ID: 10640747
[TBL] [Abstract][Full Text] [Related]
13. [Fractalkine and inflammatory diseases].
Imai T; Nishimura M; Nanki T; Umehara H
Nihon Rinsho Meneki Gakkai Kaishi; 2005 Jun; 28(3):131-9. PubMed ID: 15997176
[TBL] [Abstract][Full Text] [Related]
14. Soluble fractalkine in the cerebrospinal fluid of patients with neuropsychiatric lupus.
Sato E; Iikuni N; Yoshio T; Minota S; Kamatani N; Okamoto H
Ann Rheum Dis; 2006 Sep; 65(9):1257-9. PubMed ID: 16905589
[No Abstract] [Full Text] [Related]
15. The CX3C-chemokine fractalkine (CX3CL1) is detectable in serum of patients affected by active pityriasis rosea.
Gangemi S; Cannavò SP; Guarneri F; Merendino RA; Sturniolo GC; Minciullo PL; Di Pasquale G; Valenzise M; Drago F; Rebora A
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1366-7. PubMed ID: 17062081
[No Abstract] [Full Text] [Related]
16. Tissue-specific differential antitumour effect of molecular forms of fractalkine in a mouse model of metastatic colon cancer.
Vitale S; Cambien B; Karimdjee BF; Barthel R; Staccini P; Luci C; Breittmayer V; Anjuère F; Schmid-Alliana A; Schmid-Antomarchi H
Gut; 2007 Mar; 56(3):365-72. PubMed ID: 16870716
[TBL] [Abstract][Full Text] [Related]
17. Activation of human natural killer cells by recombinant membrane-expressed fractalkine on the surface of tumor cells.
Zhang X; Wei H; Chen Q; Tian Z
Oncol Rep; 2007 Jun; 17(6):1371-5. PubMed ID: 17487393
[TBL] [Abstract][Full Text] [Related]
18. Intervention of MAdCAM-1 or fractalkine alleviates graft-versus-host reaction associated intestinal injury while preserving graft-versus-tumor effects.
Ueha S; Murai M; Yoneyama H; Kitabatake M; Imai T; Shimaoka T; Yonehara S; Ishikawa S; Matsushima K
J Leukoc Biol; 2007 Jan; 81(1):176-85. PubMed ID: 17053165
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammation.
Bjerkeli V; Damås JK; Fevang B; Holter JC; Aukrust P; Frøland SS
Rheumatology (Oxford); 2007 Sep; 46(9):1422-7. PubMed ID: 17616549
[TBL] [Abstract][Full Text] [Related]
20. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets.
Schulz C; Schäfer A; Stolla M; Kerstan S; Lorenz M; von Brühl ML; Schiemann M; Bauersachs J; Gloe T; Busch DH; Gawaz M; Massberg S
Circulation; 2007 Aug; 116(7):764-73. PubMed ID: 17679613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
